Pharma academic research - Indian patent applications published on 12th February 2016


Every week of thousands of patent applications are published in India. The patent applications filed by the pharma academic research institutes in India go un-noticed.

We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes. For details of these patents, please write back to us at pharmaliterati@gmail.com

Invention
Application No
Inventors
Institute
12th February, 2016
Directly compressible DIFRA starch with improved binding, disintegrate and flow properties
201621002062A
1) Naseem Ahmad Charoo
2) Daud Baraka Abdallah
3) Aamer Roshan Ali Khatri
4) Abubakr Suliman Algorashi
Not known
5-nitrofuranyl-4-oxo-2-thioxothiazolidin-3-YL derivatives for the treatment of tuberculosis
2436/MUM/2014A
1) Gupta Revathi Arun
RKDF institute of Pharmaceutical Sciences, Indore, Madhya Pradesh.
Novel antiviral combination for treating asian and east central south african genotypes of chikungunya and dengue virus
3266/CHE/2014A
1) Prof. Dr. Rajarajan Swaminathan
2) Sangeetha Kothandan
University of Madras.
Novel antiviral combination for treating asian and east central south african genotypes of chikungunya virus and method for producing the same
3267/CHE/2014A
1) Prof. Dr. Rajarajan Swaminathan
2) Sangeetha Kothandan
University of Madras.
Novel compound as an antiviral agent against the asian and east central south african genotypes of chikungunya and dengue virus
3268/CHE/2014A
1) Prof. Dr. Rajarajan Swaminathan
2) Sangeetha Kothandan
University of Madras.
Novel compound for treating sensitive, isoniazid resistant strains and multi drug resistant mycobacterium tuberculosis
3269/CHE/2014A
1) Prof. Dr. Rajarajan Swaminathan
2) Dr. Soundhari Chidambaram
University of Madras.
Novel compound for treating sensitive, isoniazid resistant strains and multi drug resistant mycobacterium tuberculosis
3270/CHE/2014A
1) Prof. Dr. Rajarajan Swaminathan
2) Dr. Soundhari Chidambaram
University of Madras.
Delivery of telmisartan by making formulations containing nanocrystals or disordered crystals of it and a process without use of alkalanizers or solvents for the preparation thereof.
830/KOL/2014A
1) Jinu Isaac
2) Animesh Ghosh
3) Swastika Ganguly
4) Santanu Kaity
Department of Pharmaceutical Science & Technology, Birla Institute of Technology (BIT), Ranchi, Jharkhand.

Comments

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

PHYTOCON 2018 - Commercialization of medicinal plant products: Lab techniques to trade_14 April 2018